Human SNP ID | rs977396 |
---|---|
Human chromosome | chr8 |
Human SNP position | 104980468 |
Pig chromosome | chr4 |
Pig SNP position | 35003098 |
PubMed ID | 20195266 |
---|---|
Journal | Mol Psychiatry |
Link | www.ncbi.nlm.nih.gov/pubmed/20195266 |
Study | Genomewide pharmacogenomic study of metabolic side effects to antipsychotic drugs. |
Disease/Trait | Response to antipsychotic treatment |
Initial sample | 421 European ancestry, 214 African American, and 103 cases |
Replication sample | NA |
Region | 8q22.3 |
Chromosome id | chr8 |
Chromosome position | 104980468 |
Reported gene | intergenic |
Mapped gene | LOC105375694 - RPL29P18 |
Upstream gene id | 105375694 |
Downstream gene id | 644103 |
SNP gene ids | |
Upstream gene distance | 84751 |
Downstream gene distance | 30599 |
SNP risk allele | rs977396-? |
SNPs | rs977396 |
Merged | 0 |
SNP id current | 977396 |
Context | intron_variant |
Intergenic | 1 |
Allele frequency | 0.089 |
P value | 0.0000003 |
Pvalue mlog | 6.52287874528033 |
P value text | (olanzapine-total cholesterol) |
Or beta | |
%95 Ci | |
Platform | Affymetrix [492900] |
CNV | N |
Mapped trait | response to olanzapine |
Mapped trait URI | http://purl.obolibrary.org/obo/GO_0097333 |
Study accession | GCST000618 |